Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Ann Otol Rhinol Laryngol ; 106(8): 633-9, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9270424

ABSTRACT

In a rat model, we investigated the role of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in endotoxin-induced middle ear effusions (MEEs). After the eustachian tube was obstructed, the middle ear was transtympanically injected with 35 microL of either 1) 1 mg/ mL lipopolysaccharide (LPS); 2) LPS and 100 micrograms TNF binding protein (TNFbp); 3) LPS and 1 microgram IL-1 receptor antagonist (IL-1ra); or 4) LPS, TNFbp, and IL-1ra. Every 2 hours, the fluid within the middle ear was collected, and the quantity of albumin in the fluid, an index of vascular leakage, was determined by enzyme-linked immunosorbent assay. After 6 hours, the middle ear was fixed for histologic analysis. The TNFbp significantly attenuated vascular extravasation into the middle ear. The IL-1ra did not significantly alter effusion development. These results indicate that TNF, but not IL-1, is a mediator of LPS-induced MEE. Therefore, TNFbp may represent a novel approach to the treatment of otitis media with effusion.


Subject(s)
Interleukin-1/physiology , Lipopolysaccharides , Otitis Media with Effusion/physiopathology , Pseudomonas aeruginosa , Receptors, Tumor Necrosis Factor , Tumor Necrosis Factor-alpha/physiology , Albumins/analysis , Animals , Carrier Proteins/pharmacology , Ear, Middle/pathology , Mucous Membrane/pathology , Otitis Media with Effusion/etiology , Otitis Media with Effusion/metabolism , Otitis Media with Effusion/pathology , Rats , Rats, Sprague-Dawley , Receptors, Interleukin-1/antagonists & inhibitors , Receptors, Tumor Necrosis Factor, Type I , Tumor Necrosis Factor Decoy Receptors
2.
J Clin Endocrinol Metab ; 82(7): 2093-6, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9215277

ABSTRACT

The adrenal steroids, dehydroepiandrosterone (DHEA) and its sulfate (DHEAS), have attracted attention for their possible antiaging effects. DHEAS levels in humans decline markedly with age, suggesting the potential importance of this parameter as a biomarker of aging. Here we report that, as seen in humans, male and female rhesus monkeys exhibit a steady, age-related decline in serum DHEAS. This decline meets several criteria for a biomarker of aging, including cross-sectional and longitudinal linear decreases with age and significant stability of individual differences over time. In addition, the proportional age-related loss of DHEAS in rhesus monkeys is over twice the rate of decline observed in humans. Most important is the finding that, in rhesus monkeys, calorie restriction, which extends life span and retards aging in laboratory rodents, slows the postmaturational decline in serum DHEAS levels. This represents the first evidence that this nutritional intervention has the potential to alter aspects of postmaturational aging in a long-lived species.


Subject(s)
Aging , Biomarkers/analysis , Dehydroepiandrosterone Sulfate/blood , Energy Intake , Analysis of Variance , Animals , Female , Macaca mulatta , Male
3.
Hear Res ; 99(1-2): 1-6, 1996 Sep 15.
Article in English | MEDLINE | ID: mdl-8970807

ABSTRACT

The presence of active nitric oxide synthase (NOS) in the spiral ganglion cells of the cochlea suggests that the neuromodulator nitric oxide (NO) may play a role in hearing. This study investigated the effects of sodium nitroprusside (SNP), an NO donor, upon cochlear function mediated through its activation of guanylate cyclase. In gerbils, cochlear compound action potential (CAP) thresholds were recorded after cochlear perfusions of control and test solutions in four experimental groups. Perfusions were performed using the following: artificial perilymph solution (APS); the NO donor SNP; the guanylate cyclase inhibitor methylene blue (MB); and sodium dodecyl sulfate (SDS), which facilitates MB entrance into cells. SNP caused significant elevations of CAP thresholds from baseline (25 dB SPL +/- 1.54 dB to 64.3 dB SPL +/- 2.54 dB). SNP with MB also resulted in significant CAP threshold elevations (29.4 dB SPL +/- 4.27 dB to 38.1 dB SPL +/- 4.0 dB); however, these elevations were significantly lower than those seen in SNP perfusions without MB. Drilling perfusion holes and perfusion of APS, APS/SDS, and MB/SDS/APS solutions did not significantly affect CAP thresholds. These results suggest that the NO donor nitroprusside does affect cochlear neuromodulation and effects this mediation in part through NO activation of guanylate cyclase.


Subject(s)
Auditory Threshold/drug effects , Cochlea/drug effects , Nitroprusside/toxicity , Vasodilator Agents/toxicity , Action Potentials/drug effects , Analysis of Variance , Animals , Auditory Threshold/physiology , Blood Pressure/drug effects , Blood Pressure/physiology , Cochlea/metabolism , Cochlea/physiology , Cyclic GMP/metabolism , Gerbillinae , Guanylate Cyclase/antagonists & inhibitors , Guanylate Cyclase/metabolism , Methylene Blue/toxicity , Perfusion , Perilymph/drug effects , Perilymph/metabolism , Sodium Dodecyl Sulfate/toxicity
4.
Laryngoscope ; 106(8): 1021-7, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8699894

ABSTRACT

Using a rat model, the authors investigated the role of nitric oxide (NO) in endotoxin-induced middle ear effusion (MEE). After the eustachian tube was obstructed, the middle ear was transtympanically injected with 35 microL of either 1 mg/mL lipopolysaccharide (LPS) or LPS and 1 mmol/L N-nitro-L-arginine methyl ester (L-NAME), a competitive inhibitor of NO synthase. Over the next 6 hours, the fluid within the middle ear was collected every 2 hours, and the quantity of albumin in the fluid, an index of vascular leakage, was determined using enzyme-linked immunosorbent assay. L-NAME significantly reduced LPS-induced vascular extravasation into the middle ear. Inoculation of the ear with L-arginine, the substrate for NO synthase, reversed the effects of L-NAME. These results indicate that NO is a mediator of LPS-induced MEE. Therefore, inhibition of NO synthase may represent a novel approach to the treatment of otitis media with effusion.


Subject(s)
Arginine/analogs & derivatives , Enzyme Inhibitors/administration & dosage , Lipopolysaccharides/administration & dosage , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide/physiology , Otitis Media with Effusion/drug therapy , Otitis Media with Effusion/physiopathology , Albumins/analysis , Animals , Arginine/administration & dosage , Enzyme-Linked Immunosorbent Assay , NG-Nitroarginine Methyl Ester , Otitis Media with Effusion/pathology , Rats , Time Factors
5.
Otolaryngol Head Neck Surg ; 113(5): 541-9, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7478643

ABSTRACT

This study was designed to investigate the presence of nitric oxide in human squamous cell carcinoma of the head and neck. We localized the activity of nitric oxide synthase in these tumors through immunohistochemical analysis using antibodies to L-citrulline (a byproduct of nitric oxide synthase), to inducible nitric oxide synthase, and to constitutive nitric oxide synthase. We found presence of inducible enzyme in squamous cells throughout these tumors, with the highest intensity staining occurring directly around keratin pearls. Our findings suggest that inducible nitric oxide synthase activity is present in squamous cell carcinomas of the head and neck, leading us to conclude that inducible nitric oxide synthase may play a significant role in tumor growth.


Subject(s)
Awards and Prizes , Carcinoma, Squamous Cell/enzymology , Head and Neck Neoplasms/enzymology , Nitric Oxide Synthase/metabolism , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , Immunoenzyme Techniques , Keratins/metabolism , Mouth Mucosa/cytology , Mouth Mucosa/metabolism , Nitric Oxide/metabolism
6.
J Nutr ; 125(6): 1600-10, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7782913

ABSTRACT

Food restriction increases life span, reduces aging rate and affects a wide variety of biological functions. In rats, food restriction delays bone growth and reduces bone density and mineral content. We report the effects of aging and long-term (> 6.0 y) food restriction on several indices of bone growth and metabolism in rhesus monkeys (Macaca mulatta). Food allotments for controls approximated free access consumption, whereas food-restricted monkeys received 30% less food on a body weight basis. Cross-sectional and longitudinal age effects on serum alkaline phosphatase paralleled those reported for humans. Food restriction induced a significant delay in the developmental decline (to adult levels) in total alkaline phosphatase and significantly suppressed serum interleukin 6 concentrations, particularly in younger monkeys. Also, food restriction slowed skeletal growth, as reflected by shorter crown-rump length, and significantly reduced total body bone mineral content, but not bone mineral density, measured by dual energy X-ray absorptiometry. Analyses of serum parathyroid hormone, calcium, phosphate and osteocalcin concentrations suggested that the effects on skeletal growth were not related to alterations in calcium and phosphate homeostasis or a primary defect in bone formation. These findings suggest that long-term food restriction delays skeletal development in male rhesus monkeys while allowing the development of a reduced but otherwise normal skeleton.


Subject(s)
Aging/physiology , Bone Development/physiology , Bone and Bones/metabolism , Food Deprivation/physiology , Macaca mulatta/metabolism , Alkaline Phosphatase/analysis , Alkaline Phosphatase/blood , Animals , Bone Density/physiology , Bone and Bones/enzymology , Bone and Bones/physiology , Calcium/blood , Homeostasis/physiology , Interleukin-6/blood , Liver/enzymology , Macaca mulatta/physiology , Male , Osteocalcin/blood , Parathyroid Hormone/blood , Phosphates/blood , Time Factors
7.
J Morphol ; 224(3): 265-91, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7541086

ABSTRACT

The jaw, suprahyoid, and extrinsic tongue muscles are described for eight species of New World squirrels, spanning more than an order of magnitude in body mass. Anatomical differences are discussed in the light of body size, natural history, and phylogeny. The relative sizes of different muscles, their orientations, and the shapes and positions of their areas of attachment vary but show few trends in relation to body size. The anatomical differences are likewise not readily explained by the mechanical requirements of the animals' diets, which are similar. The most marked anatomical differences occur in Sciurillus (the pygmy tree squirrel), as well as those genera--Glaucomys (the flying squirrel) and Tamias (the chipmunk)--that are taxonomically most distinct from the tree squirrels. Sciurillus is noteworthy for its unusually small temporalis and an anterior deep masseter that is oriented to assist in retraction of the jaw. Tamias has a more vertically oriented temporalis and greater inclination in the anterior masseter muscles than the other squirrels, features that may be associated with its large diastema and relatively posteriorly situated cheek teeth, which in turn may relate to its having cheek pouches. Our results form a valuable database of information to be used in further studies of functional morphology and phylogeny.


Subject(s)
Jaw/anatomy & histology , Muscles/anatomy & histology , Sciuridae/anatomy & histology , Americas , Animals , Masticatory Muscles/anatomy & histology , Muscle Fibers, Skeletal/cytology , Phylogeny , Species Specificity , Tongue/anatomy & histology
8.
Am J Physiol ; 268(5 Pt 1): E941-8, 1995 May.
Article in English | MEDLINE | ID: mdl-7762649

ABSTRACT

Male rhesus monkeys (Macaca mulatta) of different age groups representing the species life span were fed ad libitum or a 30% reduced calorie diet over a 7-yr period. During the first 2-3 yr of this longitudinal study, glucose and insulin levels were not altered by diet restriction (DR). However, reductions in fasting blood glucose became apparent in DR animals after 3-4 yr. At the end of the 6th yr of study, glycated hemoglobin was measured, and intravenous glucose tolerance tests (IVGTTs) were conducted. Maximum glucose levels reached during IVGTTs increased with age but were lower in DR animals compared with controls. Several measures of the insulin response (baseline, maximum, and integrated areas under curve) increased with age and were lower in DR monkeys. With the exception of glycated hemoglobin, which was not different in monkeys subjected to DR, these findings confirm previous studies in rodents demonstrating that DR alters glucose metabolism and may be related to the antiaging action of this intervention.


Subject(s)
Diet , Fasting , Food Deprivation , Glucose/pharmacology , Glucose/physiology , Aging/metabolism , Animals , Blood Glucose/analysis , Glucose Tolerance Test , Glycated Hemoglobin/analysis , Insulin/blood , Macaca mulatta , Male , Reference Values
10.
Article in English | MEDLINE | ID: mdl-1482900

ABSTRACT

SENEX is a computer program for students, educators, and research investigators in the domain of molecular pathology. The application allows an individual to ask a sequence of questions in a single interactive session, thereby facilitating the development and testing of several hypotheses in a short period of time. Graphical representations of molecules and molecular events help enable individuals to grasp spatial and functional relationships (and in the future, temporal relationships) among molecules, cellular compartments, and cell regions. Fairly simple but well-defined reasoning capabilities allow an individual to ask sophisticated questions and to predict novel molecular events or pathways. SENEX contains information about: 1) molecules and the motifs that impart function to these molecules; 2) molecular events; 3) cell-specific expression of genes; 4) disease processes. SENEX is being developed through object-oriented programming in a portable programming environment supported by COMMON LISP and the COMMON LISP INTERFACE MANAGER.


Subject(s)
Molecular Biology , Pathology , Software , Data Display , Terminology as Topic , User-Computer Interface
11.
Comput Appl Biosci ; 7(2): 175-87, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2059842

ABSTRACT

The SENEX project is exploring knowledge representation in the neurobiology of ageing through object-oriented programming. SENEX is built from a classification structure of biologic entities and significant relationships among them. For example, an enzyme is an entity and an enzymatic reaction is a relationship among enzyme, cofactor(s), substrate(s) and product(s). There are currently 2600 classes of entities and 50 classes of relationships in SENEX. The class structure serves several functions. One function is to interrelate general and specific categories of molecular and morphologic entities. For example, tyrosine kinase and serine/threonine kinase are specific types of the more general class of protein kinase enzymes. Another function of the class structure is to serve as a network through which inheritance of attributes may occur. For example, the attribute 'subunits' is inherited by all subclasses of the general class multisubunit protein. Information may be accessed through links established in the class structure and through links relating one object as part of another. Relationships form the basis of separate modules within SENEX. This paper describes the types of relationships currently used and planned in the representation of age-related changes in cellular signal transduction processes of mammalian central nervous systems. We also describe tools for specific retrieval of relationships and for tracing links in complex reaction cascades. Application of these tools to identifying possible signal transduction pathways to guide further exploration through experimentation is discussed.


Subject(s)
Artificial Intelligence , Computer Simulation , Models, Biological , Molecular Biology/methods , Neurobiology/methods , Signal Transduction/physiology , Software , Aging/physiology , Animals , Central Nervous System/physiology , Humans , Mammals , User-Computer Interface
12.
J Gerontol ; 44(6): M195-200, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2809106

ABSTRACT

A longitudinal study of the changes in latency of the P300 (P3) wave of the auditory event-related brain potential was undertaken in a group of 18 thoroughly screened and diagnosed possible and probable Alzheimer's disease (pAD) patients and 15 normal controls. On initial recording, P3 latency was significantly prolonged in the pAD group by more than 1.5 standard deviations (40 msec) beyond the normal group. Over the course of the next 3 years, the rate of increase in P3 latency was significantly greater for the patient group than for the controls. The rate of change in P3 latency may reflect accelerated senescence in Alzheimer's disease. Development of the auditory P300 as a marker of neurobiological processes in aging and dementia is discussed.


Subject(s)
Alzheimer Disease/physiopathology , Evoked Potentials, Auditory , Aged , Aging/physiology , Humans , Longitudinal Studies , Middle Aged , Reaction Time
13.
Mutat Res ; 219(4): 241-6, 1989 Jul.
Article in English | MEDLINE | ID: mdl-2770771

ABSTRACT

Female C57BL/10 mice 2 and 14 months of age were killed 3, 6, 9, 12, 18 and 24 h after injection with 0.4 mg of benzo[a]pyrene-trans-7,8-dihydrodiol. The amount of carcinogen bound to DNA isolated from liver and kidney of each mouse was determined as benzo[a]pyrene-7,8,9,10-tetrol liberated upon acid hydrolysis of the DNA and measured by synchronous scanning fluorometry. Considerable variability was observed and a subset of animals in the middle-aged group failed to sustain appreciable damage upon injection of the carcinogen. Nevertheless, repair of DNA-bound carcinogen from both the liver and kidney of 2-month-old animals was clearly evident. In the subset of 14-month-old animals who sustained damage, evidence for removal of DNA-bound carcinogen was marginal.


Subject(s)
Aging/metabolism , DNA Adducts , DNA Damage , DNA Repair/drug effects , Dihydroxydihydrobenzopyrenes/pharmacology , Animals , Benzo(a)pyrene/metabolism , DNA/metabolism , Female , Kidney/drug effects , Kidney/metabolism , Kinetics , Liver/drug effects , Liver/metabolism , Mice , Mice, Inbred C57BL , Spectrometry, Fluorescence
14.
J Immunol Methods ; 98(2): 195-200, 1987 Apr 16.
Article in English | MEDLINE | ID: mdl-3571986

ABSTRACT

We have produced and characterized a murine monoclonal antibody that recognizes DNA modified with N-acetoxy-2-acetylaminofluorene. The effectiveness of competitive binding inhibitors in an ELISA indicates that this antibody binds most strongly to N-(guanin-8-yl)-2-acetylaminofluorene. It also binds to N-(guanin-8-yl)-2-aminofluorene, albeit some 20-fold less avidly. Thus the monoclonal antibody displays specificity generally similar to the polyclonal antisera elicited by other laboratories but having the advantage of stable and precisely defined specificities. We employed a biotin-streptavidin ELISA to demonstrate that the antibody can detect less than 10 fmol of N-(guanin-8-yl)-2-acetylaminofluorene. N-(guanin-8-yl)-2-acetylaminofluorene is a more effective competitive binding inhibitor of the antibody than is N-(2'-deoxyguanosin-8-yl)-2-acetylaminofluorene or calf thymus DNA modified with N-acetoxy-2-acetylaminofluorene. Thus the antibody should be most useful in quantifying the persistence of N-acetoxy-2-acetylaminofluorene adducts in DNA hydrolyzed with trifluoroacetic acid.


Subject(s)
2-Acetylaminofluorene/analogs & derivatives , 2-Acetylaminofluorene/analysis , Acetoxyacetylaminofluorene/analysis , Antibodies, Monoclonal , Carcinogens/analysis , DNA/metabolism , Enzyme-Linked Immunosorbent Assay/methods , 2-Acetylaminofluorene/immunology , 2-Acetylaminofluorene/metabolism , Acetoxyacetylaminofluorene/immunology , Acetoxyacetylaminofluorene/metabolism , Animals , Antibody Specificity , Binding Sites, Antibody , Binding, Competitive , Carcinogens/metabolism , Hydrolysis , Mice , Trifluoroacetic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...